K

Morningside Ventures logo

Morningside Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

11

Common Fundraising Type

Equity

HOPPR logo
HOPPR

Medical AI • Imaging Infrastructure

PSG Equity logo
Morningside Capital logo
Kivu Ventures logo
Health 2047 logo

HOPPR provides infrastructure for developing and deploying AI models in medical imaging to enhance diagnostic workflows and patient care.

Series A
$31.5M
06/18/2025
Article
Xealth logo
Xealth

Digital health • Prescription platform

Morningside Ventures logo

Xealth provides a platform that enables health systems to prescribe and monitor digital health tools to enhance patient care.

Equity
Undisclosed
03/25/2025
Article
Accropeutics logo
Accropeutics

Biotechnology • Novel Therapeutics

Accropeutics is a biotechnology company developing novel therapeutics targeting molecular mechanisms of regulated cell death for immune-mediated diseases.

Series B
$12M
03/14/2025
Article
SimpliFed logo
SimpliFed

Virtual maternal healthcare • Breastfeeding support

Waterline Ventures logo
The Venture Collective logo
The Artemis Fund logo
Morningside logo

SimpliFed provides virtual maternal healthcare services, including breastfeeding support and high-risk monitoring, through a comprehensive technology platform.

Equity
$4M
02/06/2025
Article
AdvanCell logo
AdvanCell

Radiopharmaceutical • Clinical-stage

SV Health Investors logo
SymBiosis logo
Sanofi Ventures logo
Morningside logo

AdvanCell is a clinical-stage radiopharmaceutical company developing innovative cancer therapies using targeted alpha-emitting radionuclides.

Series C
$112M
02/03/2025
Article
Geneoscopy logo
Geneoscopy

Life sciences • Colorectal cancer

Geneoscopy, Inc. develops and commercializes RNA-based diagnostic tests for colorectal cancer and inflammatory bowel disease.

Series C
$105M
01/08/2025
Article
Alentis Therapeutics logo
Alentis Therapeutics

Biotech • Clinical-stage

Jeito Capital logo
Novo Holdings logo
OrbiMed logo
RA Capital Management logo

Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.

Series D
$181.4M
11/12/2024
Article
Jitjatjo logo
Jitjatjo

Gig Marketplace • Temporary Staffing

Morningside Technology Ventures logo

Jitjatjo is a gig economy marketplace that connects businesses with temporary staff as W-2 employees, offering benefits and using AI for workforce optimization, and is expanding its global presence.

Series B
$30M
12/12/2023
Article
etaily logo
etaily

E-commerce enablement • Omnichannel operations

Etaily is an e-commerce enablement platform that supports global consumer brands entering Southeast Asia by providing end-to-end solutions for e-commerce and omnichannel operations.

Series A
$17.8M
11/14/2023
Article
AdaptX logo
AdaptX

AI-driven Clinical Management • Self-serve Clinical Solutions

WRF Capital logo
Star Equity logo
Morningside Ventures logo
Memorial Hermann Health System logo

AdaptX is a Seattle-based company that specializes in self-serve clinical management solutions, using AI-driven technology to assess and improve care across patients using data from electronic medical records.

Equity
$10M
11/01/2023
Article
Epigenic Therapeutics logo
Epigenic Therapeutics

Biotechnology • Gene Editing

Qiming Venture Partners logo
OrbiMed logo
Morningside Venture Capital logo

Epigenic Therapeutics is a biotechnology company that develops gene editing therapies for various diseases using its proprietary technology platform, EPIREG, which optimizes CRISPR-Cas components for gene regulation without altering DNA sequences and employs a proprietary lipid nanoparticle medicine delivery system.

Series A
$32M
08/30/2023
Article